Skip to content
healthcare.dev

testosterone

NDC 45802-281, testosterone, gel, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-281
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205781
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-281 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TESTOSTERONE20.25 mg/1.25g

Pharmacologic classes

Androgen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]

Package NDCNDC-11Package
45802-281-394580202813930 PACKET in 1 CARTON (45802-281-39) / 1.25 g in 1 PACKET (45802-281-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/54fcdcb9-fb0e-4164-9e51-f2a5feae3217
  • NADAC price for package 45802028139

    GET /v1/drugs/nadac/45802028139

Use it

Look up 45802-281 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-281 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-281. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.